Phreesia (PHR) Net Equity Issued and Repurchased (2020 - 2021)

Phreesia (PHR) posted Net Equity Issued and Repurchased of $245.8 million for Q2 2021, up 40.63% sequentially from $174.8 million in Q4 2020.

Phreesia (PHR) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Phreesia has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $245.8 million in Q2 2021.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $245.8 million in Q2 2021, while the trailing twelve-month figure through Jan 2022 was $245.8 million (up 40.63% YoY) and the FY2022 annual result came in at $245.8 million, up 40.63% from the prior year.
Net Equity Issued and Repurchased grew to $245.8 million in Q2 2021 per PHR's latest filing, from $174.8 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $245.8 million in Q2 2021 and troughed at $174.8 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Phreesia	758.43 Mn	682.03 Mn	113.28 Mn	-

Download Data